Published in Lancet on May 07, 1983
The changing limits and incidence of malaria in Africa: 1939-2009. Adv Parasitol (2012) 1.72
Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction. Bull World Health Organ (1985) 1.19
The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara. Bull World Health Organ (1984) 1.07
Malaria parasites giving rise to recrudescence in vitro. Antimicrob Agents Chemother (2002) 0.97
Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression. Bull World Health Organ (1985) 0.92
The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal. Bull World Health Organ (1984) 0.86
[Drug resistance of Plasmodium falciparum in Burundi]. Bull World Health Organ (1985) 0.85
Increased accumulation of chloroquine and desethylchloroquine in homozygous sickle cells. Bull World Health Organ (1987) 0.78
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. Science (1986) 4.40
Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet (1992) 4.32
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
Use and limitations of light microscopy for diagnosing malaria at the primary health care level. Bull World Health Organ (1988) 3.99
Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia. Lancet (1992) 3.51
Development of indicators to assess hunger. J Nutr (1990) 3.44
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol (1992) 3.27
Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet (1979) 3.22
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Self-treatment of malaria in a rural area of western Kenya. Bull World Health Organ (1995) 3.03
Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ (1997) 2.73
Breakthrough pain: characteristics and impact in patients with cancer pain. Pain (1999) 2.53
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis (1993) 2.52
Within month variability in use of soup kitchens in New York State. p4. Am J Public Health (1988) 2.43
Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg (1996) 2.34
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet (1981) 2.32
Requesting organ donation: an interview study of donor and nondonor families. Am J Crit Care (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21
The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther (1991) 2.12
Long-term malaria prophylaxis with weekly mefloquine. Lancet (1993) 2.09
Neurologic reactions after a therapeutic dose of mefloquine. N Engl J Med (1989) 2.03
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg (1986) 2.01
Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr (1983) 1.99
Combating severe malaria in African children. Bull World Health Organ (1988) 1.94
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. JAMA (1991) 1.90
Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med (1989) 1.88
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78
Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol (1992) 1.77
An epidemiologic study of the benefits and risks of running. JAMA (1982) 1.76
Varying virulence in rabbits infected with different filamentous types of Histoplasma capsulatum. J Bacteriol (1968) 1.73
Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet (1991) 1.72
Impact of control measures on malaria transmission and general mortality. Bull World Health Organ (1976) 1.72
The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys (2001) 1.70
Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies. JAMA (1991) 1.70
Evaluation of fenitrothion for the control of malaria. Bull World Health Organ (1978) 1.69
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest (1998) 1.68
In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age. Am J Trop Med Hyg (1986) 1.65
Mosquito-transmitted malaria in New York City, 1993. Lancet (1995) 1.63
Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol (1999) 1.62
CHLORAMPHENICOL (CHLOROMYCETIN) IN EXPERIMENTAL CHOLERA INFECTIONS. J Bacteriol (1949) 1.59
Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun (1975) 1.57
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey. Bull World Health Organ (1982) 1.56
A management approach to incompletely excised basal cell carcinomas of skin. Int J Radiat Oncol Biol Phys (1991) 1.52
A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys (1993) 1.50
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med (1991) 1.46
Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet (1981) 1.43
The development of a surveillance system to monitor emergency food relief in New York State. Am J Public Health (1987) 1.42
UKCC. Confusion over porn suspensions. Nurs Times (2002) 1.39
Photodarkening in Yb-doped aluminosilicate fibers induced by 488 nm irradiation. Opt Lett (2007) 1.39
Holy water not always a blessing. BMJ (2001) 1.38
Ireland might relax fluoride rules. BMJ (2000) 1.38
Decreased regional brain metabolism after ect. Am J Psychiatry (2001) 1.33
Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS (1997) 1.32
Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol (2001) 1.31
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol (1987) 1.31
Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg (1996) 1.31
Fatal malaria in US civilians. Lancet (1985) 1.30
Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull World Health Organ (1980) 1.29
Overweight schoolchildren in New York State: prevalence and characteristics. Am J Public Health (1994) 1.27
Assessment of chloroquine sensitivity of Plasmodium falciparum in Choluteca, Honduras. Bull World Health Organ (1981) 1.25
Identification of malaria species by ELISA in sporozoite and oocyst infected Anopheles from western Kenya. Am J Trop Med Hyg (1988) 1.25
High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya. N Engl J Med (1982) 1.23
Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest (1995) 1.20
Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. Am J Trop Med Hyg (1980) 1.20
Use of prophylaxis for malaria by American travelers to Africa and Haiti. JAMA (1987) 1.19
Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ (1990) 1.19
Characterization of the Cryptosporidium antigens from sporulated oocysts of Cryptosporidium parvum. Infect Immun (1987) 1.18
Disease-surveillance and decision-making after the 1976 Guatemala earthquake. Lancet (1977) 1.17
Blood transfusion practices and blood-banking services in a Kenyan hospital. AIDS (1993) 1.16
Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med (1986) 1.16
Food pattern, diet quality, and related characteristics of schoolchildren in New York State. J Am Diet Assoc (1993) 1.14
Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull World Health Organ (1990) 1.14
Amino acid synthetic media for fungal pathogens based on aminopeptidase specificities: Histoplasma capsulatum, Blastomyces dermititidis, Paracoccidioides brasiliensis and Cryptococcus neoformans. Sabouraudia (1975) 1.13
Primary radiation therapy for juvenile nasopharyngeal angiofibroma. Laryngoscope (1984) 1.13
Transmission of Plasmodium vivax malaria in San Diego County, California, 1986. Am J Trop Med Hyg (1990) 1.13
Indications for the use of Fansidar in malaria. N Engl J Med (1982) 1.12
Fertilization failures and abnormal fertilization after intracytoplasmic sperm injection. Hum Reprod (1998) 1.10
Lymphoma simulating uveitis (masquerade syndrome). Can J Ophthalmol (1986) 1.09
In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax. Am J Trop Med Hyg (1985) 1.08
Identification of yeast phase of pathogenic fungi by the specificity of their aminopeptidase(s). Sabouraudia (1975) 1.07
Fulminant Plasmodium falciparum infection treated with exchange blood transfusion. JAMA (1983) 1.07
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol (1991) 1.06
Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost. Trans R Soc Trop Med Hyg (1991) 1.06
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med (1993) 1.05
Plasmodium malariae: distribution of circumsporozoite protein in midgut oocysts and salivary gland sporozoites. Exp Parasitol (1988) 1.04
Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol (1991) 1.03
Re-operation for recurrent coronary artery and graft disease. A review of 73 patients in a group of 2573 consecutive first operations. J Cardiovasc Surg (Torino) (1989) 1.02
In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. Am J Trop Med Hyg (1986) 1.02
Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982. Am J Trop Med Hyg (1983) 1.01
Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol (2000) 1.00